Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: Effect of age and risk stratification of disease

British Journal of Haematology

Volumn 129, Issue 6, 2005, Pages 803-810

  Athale, Uma H ^a,b   Siciliano, Sabrina A ^b   Crowther, Mark ^a   Barr, Ronald D ^a,b   Chan, Anthony K C ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Acute lymphoblastic leukaemia; Asparaginase; Steroids; Thromboembolism

Indexed keywords

ASPARAGINASE; DEXAMETHASONE; DOXORUBICIN; HEPARIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; RAZOXANE; STEROID; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DOSE RESPONSE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PREDNISONE; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS;

EID: 21344433625     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05528.x     Document Type: Article

References (39)

1. Andrew, M., Brooker, L. & Mitchell, L. (1994) Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia. Blood Coagulation and Fibrinolysis, 5, S24-S36.
2. Arruda, VR, von Zuben, PM, Chiaparini, LC, Annichino, JM & Costa, FF. (1997) The mutation Ala 677-val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial and venous thrombosis. Thrombosis and Hemostasis, 77, 818-821.
3. Athale, U.H. & Chan, A.K. (2003a) Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thrombosis Research, 111, 125-131.
4. Athale, U.H. & Chan, A.K.C. (2003b) Thrombosis in children with acute lymphoblastic leukemia: Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy. Thrombosis Research, 111, 199-212.
5. Clavell, L.A., Gelber, R.D., Cohen, H.J., Hitchcock-Bryan, S., Cassady, J.R., Tarbell, N.J., Blattner, S.R., Tantravahi, R., Leavitt, P. & Sallan, S.E. (1986) Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. The New England Journal of Medicine, 315, 657-663.
6. Dalle, J.H.M., Moghrabi, A.M., Rousseau, P.M., Leclerc, J.M.M., Barrette, S.M., Bernstein, M.L.M., Champagne, J.M., David, M.M., Demers, J.M., Duval, M.M., Hume, H.M., Meyer, P.R. & Champagne, M.A.M. (2005) Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols. The Journal of Pediatric Hematology/Oncology, 27, 73-79.
7. David, M. & Andrew, M. (1993) Venous thromboembolic complications in children. The Journal of Pediatrics, 123, 337-346.
8. Elhasid, R., Lanir, N., Sharon, R., Weyl Ben, A.M., Levin, C., Postovsky, S., Ben, B.A. & Brenner, B. (2001) Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia. Blood Coagulation and Fibrinolysis, 12, 367-370.
9. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Mathews, R.G., Boers, G.J.H., den Heijer, M., Kluijtmans, L.A.J., van den Heuvell, L.P. & Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111-113.
10. van Giezen, J.J. & Jansen, J.W. (1992) Inhibition of fibrinolytic activity in-vivo by dexamethasone is counterbalanced by an inhibition of platelet aggregation. Thrombosis and Haemostasis, 68, 69-73.
11. van Giezen, J.J., Brakkee, J.G., Dreteler, G.H., Bouma, B.N. & Jansen, J.W. (1994) Dexamethasone affects platelet aggregation and fibrinolytic activity in rats at different doses which is reflected by their effect on arterial thrombosis. Blood Coagulation and Fibrinolysis, 5, 249-255.
12. Guttormsen, A.B., Ueland, P.M., Lenning, P.E., Mella, O. & Refsum, H. (1998) Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapy. Clinical Chemistry, 44, 1987-1989.
13. Halton, J., Mitchell, L.G., Vegh, P.A. & Andrew, M.A. (1992) The levels of coagulation system proteins cycle in children with acute lymphoblastic leukemia (ALL) independent of L-Asparginase administration. PeiatricResearch, 4, 141A.
14. Isacson, S. (1970) The effect of prednisolone on the coagulation and fibrinolytic system. Scandanavian Journal of Haemetology, 7, 211-216.
15. Jorgenson, K.A., Sorenson, P. & Freund, L. (1982) Effect of glucocorticoids on some coagulation tests. Acta Haematologica, 68, 39-42.
16. Kishi, S., Griener, J., Cheng, C., Das, S., Cook, E.H., Pei, D., Hudson, M., Rubnitz, J., Sandlund, J.T., Pui, C.H. & Relling, M.V. (2003) Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. Journal of Clinical Oncology, 21, 3084-3091.
17. Korones, D.N., Buzzard, C.J., Asselin, B.L. & Harris, J.P. (1996) Right atrial thrombi in children with cancer and indwelling catheters. The Journal of Pediatrics, 128, 841-846.
18. Male, C, Chait, P., Ginsberg, J.S., Hanna, K., Andrew, M., Halton, J., Anderson, R., McCusker, P., Wu, J., Abshire, T., Cherrick, L, Mahoney, D. & Mitchell, L. (2002) Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thrombosis and Haemostasis, 87, 593-598.
19. Massicotte, M.P., Dix, D., Mongale, P., Adams, M. & Andrew, M. (1998) Central venous catheter related thrombosis in children: analysis of the Canadian registry of venous thromboembolic complications. The Journal of Pediatrics, 133, 770-776.
20. Mathew, L.G., Ortin, M. & Pinkerton, C.R. (2003) Thrombotic complications in children treated for ALL: single centre experience. Medical and Pediatric Oncology, 41, 310.
21. Mauz-Korholz, C., Junker, R., Gobel, U. & Nowak-Gotti, U. (2000) Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols). Thrombosis and Haemostasis, 83, 840-843.
22. Mitchell, L.G., Halton, J.M., Vegh, P.A., Barr, R.D., Venneri, T., Pai, K.M. & Andrew, M.E. (1994a) Effect of disease and chemotherapy on hemo stasis in children with acute lymphoid leukemia. The American Journal of Pediatric Hematology/Oncology, 16, 120-126.
23. Mitchell, L., Hoogendoorn, H., Giles, A.R., Vegh, P. & Andrew, M. (1994b) Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase- induced antithrombin III deficiency. Blood, 83, 386-391.
24. Mitchell, L.G., Heinz Sutor, A. & Andrew, M. (1995) Hemostasis in childhood acute lymphoblastic leukemia: Coagulopathy induced by disease and treatment. Seminars in Thrombosis and Hemostasis, 21, 390-401.
25. Monagle, P., Michelson, A.D., Bovill, E. & Andrew, M. (2001) Antithrombotic therapy in children. Chest, 119, 344S-370S.
26. Nowak-Gottl, U., Wermes, C., Junker, R., Koch, H.G., Schobess, R., Fleischhack, G., Schwabe, D. & Ehrenforth, S. (1999) Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood, 93, 1595-1599.
27. Nowak-Gottl, U., Heinecke, A., von Kries, R., Nurnberger, W., Munchow, N. & Junker, R. (2001a) Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration. Thrombosis Research, 103, 165-172.
28. Nowak-Gottl, U., Ahlke, E., Fleischhack, G., Schwabe, D., Schobess, R., Schumann, C. & Junker, R. (2003) Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood, 101, 2529-2533.
29. Nowak-Gottle, U., Kosch, A. & Schlegel, N. (2001b) Thromboembolism in newborns, infants and children. Thrombosis and Haemostasis, 86, 464-474.
30. Ozsoylu, S., Strauss, H.S. & Diamond, L.K. (1962) Effects of corticosteroids on coagulation of the blood. Nature, 195, 1214-1215.
31. Ozturk, G., Ozsoylu, S. & Gursel, T. (1994) Effects of methylprednisolone on FVIII:C and vWF levels. European Journal of Haematology, 53, 119-120.
32. Patrassi, G.M., Sartori, M.T., Viero, M.L., Scarano, L., Boscaro, M. & Girolami, A. (1992) The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state. Blood Coagulation and Fibrinolysis, 3, 789-793.
33. Patrassi, G.M., Sartori, M.T., Rigotti, P., Di Landro, D., Theodoridis, P., Fioretti, M., Capalbo, M., Saggiorato, G., Boeri, G. & Girolami, A. (1995) Reduced fibrinolytic potential one year after kidney transplantation: relationship to long-term steroid treatment. Transplantation, 59, 1416-1420.
34. Refsum, H., Wesenberg, F. & Ueland, P.M. (1991) Plasma homocystein in children with acute lymphoblastic leukemia. Changes during chemotherapeutic regimen including methotrexate. Cancer Research, 51, 828-835.
35. Sartori, T.M., Maurizio, P.G., Sara, P., Ugolino, L., Annalisa, A., Panagiotis, T., Massimo, F. & Antonio, G. (1999) Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation. The Journal of Heart and Lung Transplantation, 18, 693-700.
36. Silverman, L.B., Declerck, L., Gelber, R.D., Dalton, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Lipton, J.M., Cohen, H.J. & Sallan, S.E. (2000) Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia, 14, 2247-2256.
37. Silverman, L.B., Gelber, R.D., Dalton, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Arkin, S., Declerck, L., Cohen, H.J. & Sallan, S.E. (2001) Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood, 97, 1211-1218.
38. Wermes, C., von Depka Prondzinski, M., Lichtinghagen, R., Barthels, M., Welte, K. & Sykora, K.W. (1999) Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters. European Journal of Pediatrics, 158, S143-S146.
39. Zanon, P.D.B., Fornasiero, L., Boscaro, M., Cappellato, G., Fabris, F. & Girolami, A. (1982) Increased factor VIII associated activities in Cushing's Syndrome: a probable hypercoagulable state. Thrombosis and Haemostasis, 47, 116-117.